Venus Remedies Limited is engaged in manufacturing and trading of medicines. The Company offers pharmaceutical formulations. The Company offers around 75 products for therapeutic segments, including oncology, anti-infective, neurology, cardiology, orthopaedic, pain management, paediatrics and surgery. The Company's manufacturing facilities include Panchkula and Baddi in India, and a facility in Werne, Germany. Its Panchkula manufacturing facility manufactures products, such as Mebatic, Calridol, Moximicin, Neurotol and Glutapep, among others. Its Baddi manufacturing facility manufactures brands, such as Doxol, Paxol, Citabol, Epirol, Ronem, Immunox, Pimcef, Fejet IV, Parin-E, Vanconex, Dobutacard, Sulbactomax, Supime, Tobracef, Pirotum, Texedol, Potentox, Elores, Tobracef, Achnil and Vancoplus, among others. Its Werne manufacturing facility is engaged in out-licensing CTDs, site variation projects, testing and batch release for European markets and warehousing and logistics support.